Medical Doctor Program year 2024 Reported 2019–2024 Source: CMS Open Payments, 2026 publication

Catherine Frenette

Gastroenterology La Jolla, CA Medical Doctor

NPI 1417935081 CMS profile 154462

10666 N Torrey Pines Rd, N200, La Jolla, CA 92037

Open in the dashboard

General payments

$342,325

380 records reported · program years 2019–2024

Research payments

$0

Paid to them · None reported · program years 2019–2024

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$1,445,150 paid to institutions, not to them · program years 2019–2023

Through program year 2024, Catherine Frenette of La Jolla, CA is reported in the CMS Open Payments database as having received $342,325 across 380 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $1,445,150 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 98th percentile of Gastroenterology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $56 1
2023 General $109 1
2022 General $7,985 7
2021 General $28,034 41
2020 General $121,340 109
2019 General $184,800 221

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Catherine Frenette
  • Gastroenterology median
  • Middle half of Gastroenterology
  • National median

In program year 2025, general payments to Catherine Frenette were reported at $0. Among 13,050 Gastroenterology profiles paid that year, the median was $639 and the middle half received between $167 and $1,700.

Show as a table
Year Catherine Frenette Gastroenterology median Middle half National median
2019 $184,800 $417 $126–$1,100 $163
2020 $121,340 $224 $74–$624 $114
2021 $28,034 $352 $106–$1,054 $132
2022 $7,985 $448 $129–$1,270 $149
2023 $109 $533 $150–$1,390 $160
2024 $56 $605 $160–$1,606 $164
2025 $0 $639 $167–$1,700 $169

Breakdown

Who paid General payments · program years 2019–2024
  1. Eisai Inc. $85,232 81 payments
  2. Gilead Sciences, Inc. $65,889 78 payments
  3. Exelixis Inc. $58,538 54 payments
  4. Bayer HealthCare Pharmaceuticals Inc. $36,886 26 payments
  5. Genentech USA, Inc. $21,382 13 payments
  6. E.R. Squibb & Sons, L.L.C. $20,579 21 payments
  7. AbbVie, Inc. $13,334 21 payments
  8. Salix Pharmaceuticals, a division of Bausch Health US, LLC $10,082 27 payments
  9. Shionogi Inc $9,376 14 payments
  10. Intercept Pharmaceuticals, Inc. $6,308 12 payments
  11. Other $14,721 33 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2024
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $193,105 74 payments
  2. Consulting Fee $99,680 48 payments
  3. Travel and Lodging $25,545 62 payments
  4. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $12,800 7 payments
  5. Food and Beverage $7,710 178 payments
  6. Honoraria $3,420 5 payments
  7. Education $65 6 payments
Products named General payments · program years 2019–2024
  1. Lenvima $85,195 80 payments
  2. Epclusa $50,508 42 payments
  3. CABOMETYX $46,900 45 payments
  4. Nexavar $22,681 17 payments
  5. TECENTRIQ $21,417 13 payments
  6. MAVYRET $13,316 20 payments
  7. OPDIVO $13,265 15 payments
  8. Stivarga $12,689 12 payments
  9. XIFAXAN $10,082 27 payments
  10. Mulpleta $9,376 14 payments
  11. Other $23,187 53 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

380 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Gastroenterology in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record